Combining Language Therapy With rTMS in Aphasia

NCT03629665 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2018-08-14

No results posted yet for this study

Summary

With the present RCT, the investigators aimed at finding an optimal protocol for the neurorehabilitation of chronic post-stroke aphasia by combining two promising methods, ILAT (Intensive language action therapy) and 1-Hz rTMS to the right-hemispheric homologue of the anterior language area of Broca (pars triangularis), thus taking advantage of recent research in speech and language sciences, neurorehabilitation and brain research.

Conditions

  • Aphasia

Interventions

BEHAVIORAL

Intensive Language-Action Therapy (ILAT)

ILAT includes communicative language games played in an interactive small-group setting. Three persons with aphasia and one therapist sit around a table and have picture cards in front of them. The card sets include two items of each object or action picture. All participants take turns in making verbal requests. There will be 5 daily sessions (3 hours per session) for two weeks.

DEVICE

Repetitive navigated Transcranial Magnetic Stimulation during naming training

Magnetic stimulation will delivered with a figure-of-eight cooled coil of Navigated Brain Stimulation System during picture naming training. The primary targeted area is the right pars triangularis. In each session, rTMS will be applied at 1-Hz for 20 minutes, 5 daily sessions per week for four weeks.

Sponsors & Collaborators

  • Hospital District of Helsinki and Uusimaa

    collaborator OTHER
  • Aalto University

    collaborator OTHER
  • Freie Universität Berlin

    collaborator OTHER
  • Paula Heikkinen

    lead OTHER

Principal Investigators

  • Anu Klippi, Professor · University of Helsinki

  • Jyrki Mäkelä, MD · BioMag Laboratory, Helsinki University Hospital

  • Friedemann Pulvermüller, Professor · Brain Language Laboratory, Department of Philosophy and Humanities, WE4, Freie Universität Berlin

  • Risto Ilmoniemi, Professor · Department of Neuroscience and Biomedical Engineering, Aalto University School of Science

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-02
Primary Completion
2014-03-01
Completion
2014-03-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03629665 on ClinicalTrials.gov